An AI Scientist Proposed an ADHD Treatment on the Blockchain: BIO Price Surges

By: crypto insight|2026/04/17 19:00:02

Key Takeaways:

Bio Protocol’s crypto has soared 90% following a $6.9M funding boost for its AI-native platform, Bio V2.
The funding was led by Maelstrom Fund and aims to facilitate onchain fundraising and autonomous AI co-scientists.
Bio Protocol’s scientific proposal for an ADHD treatment targeting orexin receptors drove excitement in crypto-science circles.
BIO’s recent price spike of 40% from a low-liquidity range highlights volatility in DeSci investments.
LiquidChain is developing cross-chain infrastructure to support emerging DeSci and DeFi applications.

WEEX Crypto News, 2026-04-17 07:14:58

Decentralized Science and BIO Crypto’s Surge

Bio Protocol crypto recently experienced a staggering 90% price increase, catalyzed by substantial funding advancements and innovative AI applications. With a $6.9 million financial injection from Maelstrom Fund, Bio V2—a full-stack AI-native platform—was positioned at the forefront, promising onchain fundraising capabilities and AI-driven co-scientists, known as BioAgents. This development is a significant step forward in decentralized science (DeSci), capturing the focus of traders and scientists alike.

The spotlight shone further as Bio Protocol’s scientific team proposed a peptide targeting ADHD, sparking interest across crypto-science communities. Studies have shown that ADHD patients have lower levels of orexin-A/B, key in regulating arousal and attention. While existing treatments suppress orexin activity, Bio Protocol and @peptai_ have developed a peptide labeled OX2R-004, aiming to activate the OX2R receptor—potentially redefining ADHD treatment.

Can Bio Protocol Maintain Its Bullish Momentum?

Bio Protocol’s bold 40% price surge emerged from a low-liquidity environment, typifying DeSci’s high volatility. This sudden leap, while exciting, lacked a firm technical foundation, leading to questions about whether the spike can be sustained or will retract. Such moves are often followed by a period of consolidation or a partial pullback, determined by the balance between hype-driven interests and tangible utility.

Currently, BIO finds itself at an intersection between heightened interest and practical utility. To ensure a lasting price escalation, demand must translate into real-world usage, sustaining momentum as the narrative surpasses mere speculation. However, if Bio V2 fails to deliver measurable impact, the price may revert to its pre-announcement level. The broader crypto market also plays a role; downward trends in related tokens could influence BIO, potentially triggering a broader decline.

The Role of LiquidChain in DeSci’s Growth

LiquidChain has emerged as a potential game-changer in bridging the gap between decentralized science and decentralized finance applications. It’s constructing a Layer 3 protocol that combines Bitcoin’s financial strength, Ethereum’s DeFi capabilities, and Solana’s execution speed into a single, cohesive liquidity environment, without the need for asset wrapping. This innovation is key to supporting multi-chain DeSci initiatives.

LiquidChain’s architecture enables developers to create applications once and tap into user bases across multiple ecosystems—an attractive proposition for DeSci and DeFi projects. As of now, $674,947.04 has been raised in its presale, with tokens priced at $0.0145. However, presales harbor risks; success hinges on broader adoption rates, while premature entries have diminishing returns once catalysts are publicly realized.

-- Price

FAQ Section

What caused Bio Protocol’s price to surge by 90%?

Bio Protocol’s price increased due to a $6.9 million funding round for its AI-native platform, Bio V2, backed by Maelstrom Fund. This elevated efforts for onchain fundraising and the involvement of AI co-scientists, attracting significant interest.

Is Bio Protocol’s ADHD treatment scientifically promising?

Bio Protocol’s ADHD treatment focuses on activating the OX2R receptor with a peptide, OX2R-004. This contrasts current treatments which suppress orexin activity, offering a scientifically provocative approach to ADHD.

Can Bio Protocol sustain its current price level?

To maintain its price, Bio Protocol needs continuous demand linked to practical usage and proven utility of its platform. Hype alone can cause the price to revert once interest wanes.

What does LiquidChain offer to DeSci and DeFi projects?

LiquidChain facilitates a unified liquidity environment across blockchain ecosystems—Bitcoin, Ethereum, and Solana—thereby supporting DeSci and DeFi applications through its deploy-once framework without asset wrapping.

Are there risks associated with investing in LiquidChain’s presale?

LiquidChain’s presale carries risks, particularly due to adoption uncertainties. The potential for low initial market listings and reliance on sustained infrastructure integration poses investment challenges.

A Polymarket user supported nearly half of Trade.xyz's "active addresses" with 34,000 wallets, yet contributed less than 1% of the trading volume. The real support for the market comes from market-making institutions like Jump, Selini, and Wintermute, as well as a group of directional traders crossi...

Binance quietly placed a bet on a leading large model company

In the past year, YZi Labs has significantly accelerated its investments in the AI field, from educational agents to physical robots, and then to large models, with crypto capital and AI technology rapidly integrating.

Best Crypto Discord Server 2026: Why Jacob’s Crypto Clan Is Gaining Massive Attention

Jacob’s Crypto Clan has grown into one of the most active crypto Discord communities, with over 45K members and continuing to expand. This rapid growth reflects strong demand for structured trading insights and real-time collaboration.

Tom Lee Buying ETH: Why Wall Street’s Loudest Ethereum Bull Keeps Doubling Down

Tom Lee keeps buying ETH through every dip, every drawdown, and every moment of market doubt. Inside the strategy that's turning Ethereum into a treasury asset — and what it signals for the rest of the market.

Stripe Sessions 2026: AI Agent, Global Payments, and Invisible Crypto Infrastructure

Stablecoins have finally begun to enter the real business world, but this time, the main character may not be exchanges, wallets, or public chains, but Stripe. It encapsulates KYC, wallets, gas, compliance, and settlement, allowing businesses to access on-chain assets just like using regular payment...

Where will South Korea's cryptocurrency taxation head?

There is little time left before South Korea implements cryptocurrency taxation, but the current tax laws only cover simple spot and currency-to-currency transactions. Driven by the international tax information exchange standard (CARF), South Korea is comprehensively building an intelligence analys...

Legendary investor Naval: Apple is dead, SaaS will follow suit, and entrepreneurs have 18 months to reshape their moats

"You can continue to hold Apple stock. Just don't expect that what you hold is stock in a growth company."

Morning Report | Visa includes Polygon in its global stablecoin settlement program; MoonPay invests $100 million to acquire security company Sodot; Digital wallet platform Belo completes $14 million Series A financing

Overview of Important Market Events on April 29

Full text of the Federal Reserve's decision: Holding steady for the third consecutive time but increasing divisions

The Federal Reserve has kept interest rates unchanged for the third consecutive time, but there were internal voting disagreements, with one official advocating for a rate cut while three others opposed signaling easing. The situation in the Middle East and fluctuations in energy prices further ampl...